FDA Drug recall D-1255-2020
Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc
- FDA Drug
- Class I
- terminated
- Published 2020-04-15
On 2020-04-15 the FDA classified a Class I recall of Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc by Avet Pharmaceuticals, citing failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-1255-2020 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2020-03-23 |
| Published | 2020-04-15 |
| Last updated | 2026-09-13 11:52 UTC |
| Company | Avet Pharmaceuticals |
| Distribution | US |
Product
Tetracycline HCL Capsules, USP, 250 mg, 100-count Bottle, Rx Only, Manufactured for: Heritage Pharmaceuticals Inc. East Brunswick NJ 08816. NDC 23155-017-01
Reason
Failed Dissolution Specifications: Out of specification result during long term testing in Tetracycline HCl capsules.
Identifiers
| ndc | 23155-017-01 |
|---|---|
| ndc | 23155-018-01 |
| code_info | Lot # H190666, Exp JUL 2022 |
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:52 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1255-2020%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.